Advertisement

Index by author

April 01, 1994; Volume 269,Issue 1

A

  1. Abou-Donia, M B

    1. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;

  2. Adams, M L

    1. Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;

  3. Adamson, G M

    1. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
      G M Adamson and R E Billings
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 367-373;

  4. Agresta, C A

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

  5. Aicher, L

    1. Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;

  6. Albiero, R

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  7. Alford, G E

    1. A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;

  8. Alper, R H

    1. Adrenergic and nonadrenergic regulation of hindlimb blood flow during stress in rats.
      R H Alper and M H Zink
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 305-312;

  9. Anderson, C B

    1. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;

  10. Anderson, J K

    1. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;

  11. Ardid, D

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  12. Artibani, W

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;

  13. Asaad, M

    1. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;

  14. Aumaitre, O

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  15. Azim, S

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

B

  1. Babich, M

    1. A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;

  2. Bakry, N

    1. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;

  3. Barzago, M M

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  4. Belknap, J K

    1. Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;

  5. Benishin, C G

    1. Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;

  6. Bervoets, K

    1. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
      K Bervoets and M J Millan
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 110-120;
    2. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

  7. Betoin, F

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  8. Bianchi, R G

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  9. Biggio, G

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  10. Billings, R E

    1. Tumor necrosis factor: receptor binding and expression of receptors in cultured mouse hepatocytes.
      G M Adamson and R E Billings
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 367-373;

  11. Billman, G E

    1. The effect of adrenergic receptor antagonists on cocaine-induced ventricular fibrillation: alpha but not beta adrenergic receptor antagonists prevent malignant arrhythmias independent of heart rate.
      G E Billman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 409-416;

  12. Bombardt, P A

    1. Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;

  13. Bonati, M

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  14. Bongiorno, A

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  15. Bortolotti, A

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  16. Brewer, J E

    1. Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;

  17. Butelman, E R

    1. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;

  18. Bymaster, F P

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

C

  1. Calligaro, D O

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  2. Calpista, A

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;

  3. Canton, H

    1. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

  4. Carter, D B

    1. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;

  5. Casler, J J

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  6. Castle, N A

    1. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
      M T Slawsky and N A Castle
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 66-74;

  7. Chamienia, A L

    1. Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
      A L Chamienia and E J Johns
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 215-220;

  8. Chan, J K

    1. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

  9. Chao, C C

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

  10. Chavin, J

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

  11. Chi, S

    1. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;

  12. Chiodo, L A

    1. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;

  13. Chow, F S

    1. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;

  14. Ciaccio, M

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  15. Cicero, T J

    1. Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;

  16. Cifani, J R

    1. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

  17. Clair, P

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  18. Coffield, J A

    1. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;

  19. Collins, P W

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  20. Colombo, T

    1. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;

  21. Cooke, L

    1. Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
      L Cooke and K H Muntz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 351-357;

  22. Cooley, A J

    1. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

  23. Corcoran, J J

    1. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;

  24. Corsi, M

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;

  25. Cossum, P A

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

  26. Crabbe, J C

    1. Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;

  27. Crawshaw, L I

    1. Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;

  28. Crooke, S T

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

  29. Cuccheddu, T

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  30. Curi-Pedrosa, R

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

D

  1. D'Incalci, M

    1. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;

  2. Daujat, M

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  3. Dho, L

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  4. Domergue, J

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  5. Dubey, R K

    1. Vasodilator-derived nitric oxide inhibits fetal calf serum- and angiotensin-II-induced growth of renal arteriolar smooth muscle cells.
      R K Dubey
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 402-408;

  6. Duchene-Marullaz, P

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  7. Duescher, R J

    1. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

E

  1. Efrati, S

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  2. Elfarra, A A

    1. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

  3. Endou, M

    1. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;

  4. Eschalier, A

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

F

  1. Fenton, R L

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  2. Floris, S

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  3. Fourtanier, G

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  4. Freeman, A S

    1. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;

  5. Fuller, R W

    1. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;

G

  1. Gaviraghi, G

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
    2. Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;

  2. Gekker, G

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

  3. Gervot, L

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  4. Ghiani, C A

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  5. Giacometti, A

    1. Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;

  6. Giacomini, K M

    1. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

  7. Giusti, P

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  8. Gobert, A

    1. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

  9. Greenwood, B

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;

H

  1. Hamilton, B J

    1. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;

  2. Hemrick-Luecke, S K

    1. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;

  3. Herbet, A

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  4. Hermsmeyer, K

    1. Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
      S K Mishra and K Hermsmeyer
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 178-183;

  5. Herzer, W A

    1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;

  6. Hu, S

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

  7. Huff, R A

    1. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
      R A Huff, J J Corcoran, J K Anderson and M B Abou-Donia
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 329-335;

  8. Hui, A C

    1. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

I

  1. Imagawa, J

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

  2. Itoh, J

    1. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;

J

  1. Jackson, E K

    1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;

  2. Johns, E J

    1. Renal functional responses to the 5-HT1A receptor agonist flesinoxan: effects of controlled renal perfusion pressure.
      A L Chamienia and E J Johns
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 215-220;

  3. Johnson, M G

    1. Protein binding of tirilazad (U-74006) in human, Sprague-Dawley rat, beagle dog and cynomolgus monkey serum.
      P A Bombardt, J E Brewer and M G Johnson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 145-150;

  4. Joyeux, H

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  5. Jusko, W J

    1. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;

K

  1. Kalivas, P W

    1. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
      M A Klitenick and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 437-448;

  2. Kamei, K

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

  3. Kameyama, T

    1. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;

  4. Kang, Y S

    1. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
      Y S Kang and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 344-350;

  5. Karpinski, E

    1. Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;

  6. Kelly, G

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

  7. Kemeny, J L

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  8. Khairallah, P A

    1. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

  9. Klitenick, M A

    1. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
      M A Klitenick and P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 437-448;

  10. Koga, T

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

  11. Kost, C K

    1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;

  12. Kosten, T A

    1. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;

  13. Kowalski, D L

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  14. Kurata, Y

    1. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;

L

  1. Lash, L H

    1. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

  2. Lavarenne, J

    1. Evidence for a central long-lasting antinociceptive effect of vapreotide, an analog of somatostatin, involving an opioidergic mechanism.
      F Betoin, D Ardid, A Herbet, O Aumaitre, J L Kemeny, P Duchene-Marullaz, J Lavarenne and A Eschalier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 7-14;

  3. Layer, R T

    1. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

  4. Lesca, P

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  5. Levi, R

    1. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;

  6. Levitt, D G

    1. The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
      M D Levitt and D G Levitt
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 297-304;

  7. Levitt, M D

    1. The critical role of the rate of ethanol absorption in the interpretation of studies purporting to demonstrate gastric metabolism of ethanol.
      M D Levitt and D G Levitt
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 297-304;

  8. Lewis, J W

    1. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;

  9. Li, P

    1. Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats.
      C K Kost, W A Herzer, P Li and E K Jackson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 82-88;

  10. Livrea, M A

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  11. Long, J B

    1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;

  12. Lucchini, G

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

M

  1. Malfatto, G

    1. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;

  2. Mangino, M J

    1. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;

  3. Maresi, E

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  4. Marini, A M

    1. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;

  5. Markham, P M

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

  6. Marszalec, W

    1. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;

  7. Martin, B

    1. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;

  8. Martinez-Arizala, A

    1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;

  9. McGrath, M P

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  10. Meyer, E R

    1. Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;

  11. Micheli, D

    1. Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;

  12. Millan, M J

    1. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
      K Bervoets and M J Millan
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 110-120;
    2. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

  13. Milovanovic, M

    1. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

  14. Miserendino, M J

    1. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;

  15. Mishra, S K

    1. Resting state block and use independence of rat vascular muscle Ca++ channels by Ro 40-5967.
      S K Mishra and K Hermsmeyer
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 178-183;

  16. Mitch, C H

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  17. Mitchell, S R

    1. Quantitative trait loci mapping of genes that influence the sensitivity and tolerance to ethanol-induced hypothermia in BXD recombinant inbred mice.
      J C Crabbe, J K Belknap, S R Mitchell and L I Crawshaw
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 184-192;

  18. Molinoff, P B

    1. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
      C D Unsworth and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 246-255;

  19. Moravec, C S

    1. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

  20. Motzo, C

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  21. Muntz, K H

    1. Differences in beta adrenergic receptor agonist affinity between cardiac myocytes and coronary arterioles in canine heart.
      L Cooke and K H Muntz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 351-357;

  22. Murphy, M K

    1. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
      M J Mangino, M K Murphy and C B Anderson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 75-81;

N

  1. Nabata, H

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

  2. Nagata, K

    1. Dual action of the cyclodiene insecticide dieldrin on the gamma-aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons.
      K Nagata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 164-171;

  3. Narahashi, T

    1. Selective effects of alcohols on gamma-aminobutyric acid A receptor subunits expressed in human embryonic kidney cells.
      W Marszalec, Y Kurata, B J Hamilton, D B Carter and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 157-163;
    2. Dual action of the cyclodiene insecticide dieldrin on the gamma-aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons.
      K Nagata and T Narahashi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 164-171;

  4. Nestler, E J

    1. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion.
      T A Kosten, M J Miserendino, S Chi and E J Nestler
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 137-144;

  5. Nissenson, R A

    1. A novel phospholipase C inhibitor and phorbol esters reveal selective regulation of thrombin- and parathyroid hormone-stimulated signaling pathways in rat osteosarcoma cells.
      M Babich, G E Alford and R A Nissenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 172-177;

  6. Niwano, Y

    1. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;

  7. Nowak, G

    1. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

O

  1. Olesen, P H

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  2. Oleshansky, M A

    1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;

  3. Omarini, D

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  4. Omiecinski, C J

    1. Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;

  5. Ott, R J

    1. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

  6. Ourlin, J C

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  7. Owens, S R

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

P

  1. Palea, S

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;

  2. Pardridge, W M

    1. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
      Y S Kang and W M Pardridge
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 344-350;

  3. Patrono, C

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  4. Paul, I A

    1. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

  5. Paul, S M

    1. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;

  6. Perkins, W E

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  7. Peterson, P K

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

  8. Pichard, L

    1. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
      R Curi-Pedrosa, M Daujat, L Pichard, J C Ourlin, P Clair, L Gervot, P Lesca, J Domergue, H Joyeux and G Fourtanier
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 384-392;

  9. Piekoszewski, W

    1. Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits.
      W Piekoszewski, F S Chow and W J Jusko
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 103-109;

  10. Pietra, C

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;

  11. Poli, E

    1. Histamine H3-receptor signaling in the heart: possible involvement of Gi/Go proteins and N-type Ca++ channels.
      M Endou, E Poli and R Levi
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 221-229;

  12. Popik, P

    1. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

  13. Puniak, M A

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

R

  1. Ramanathan, V K

    1. Effect of phenylisothiocyanate on organic cation transport in opossum kidney cells.
      R J Ott, J K Chan, V K Ramanathan, A C Hui and K M Giacomini
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 204-208;

  2. Ren, J

    1. Inhibition of a K+ current by beta-dendrotoxin in primary and subcultured vascular smooth muscle cells.
      J Ren, E Karpinski and C G Benishin
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 209-214;

  3. Rigamonti, D D

    1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;

  4. Rimoldi, O

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  5. Rivet, J M

    1. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

  6. Rogers, W L

    1. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;

  7. Ruhe, T

    1. Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
      C S Moravec, T Ruhe, J R Cifani, M Milovanovic and P A Khairallah
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 290-296;

S

  1. Salvati, P

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  2. Salzman, S K

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

  3. Sanbe, A

    1. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;

  4. Sausen, P J

    1. Roles of cysteine conjugate beta-lyase and S-oxidase in nephrotoxicity: studies with S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-L-cysteine sulfoxide.
      L H Lash, P J Sausen, R J Duescher, A J Cooley and A A Elfarra
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 374-383;

  5. Sawyer, B D

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;

  6. Schoepp, D D

    1. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  7. Schwartz, P J

    1. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;

  8. Serra, M

    1. Imidazenil, a new partial agonist of benzodiazepine receptors, reverses the inhibitory action of isoniazid and stress on gamma-aminobutyric acidA receptor function.
      M Serra, C A Ghiani, C Motzo, T Cuccheddu, S Floris, P Giusti and G Biggio
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 32-38;

  9. Sewing, B N

    1. Effects of nitric oxide-related agents on rat testicular function.
      M L Adams, E R Meyer, B N Sewing and T J Cicero
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 230-237;

  10. Seymour, A A

    1. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;

  11. Shannon, H E

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  12. Shea, J P

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

  13. Sheardown, M J

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  14. Sheldon, J H

    1. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;

  15. Sheng, W S

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

  16. Simpson, L L

    1. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
      L L Simpson, J A Coffield and N Bakry
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 256-262;

  17. Sirover, M A

    1. New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;

  18. Skolnick, P

    1. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
      I A Paul, G Nowak, R T Layer, P Popik and P Skolnick
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 95-102;

  19. Slawsky, M T

    1. K+ channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes.
      M T Slawsky and N A Castle
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 66-74;

  20. Smith, P L

    1. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
      A A Seymour, J H Sheldon, P L Smith, M Asaad and W L Rogers
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 263-270;

  21. Snoddy, H D

    1. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
      R W Fuller, S K Hemrick-Luecke and H D Snoddy
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 132-136;

  22. Sonsalla, P K

    1. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
      I Terleckyj and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 44-50;

  23. Stellari, F F

    1. Mefloquine transfer during in vitro human placenta perfusion.
      M M Barzago, D Omarini, A Bortolotti, F F Stellari, G Lucchini, S Efrati and M Bonati
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 28-31;

  24. Stolzenbach, J C

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  25. Sugo, I

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

  26. Suzdak, P D

    1. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  27. Swenson, L

    1. Developmental expression of human microsomal epoxide hydrolase.
      C J Omiecinski, L Aicher and L Swenson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 417-423;

T

  1. Takeo, S

    1. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;

  2. Tallarida, R J

    1. New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;

  3. Tanonaka, K

    1. Improvement of cardiac function and myocardial energy metabolism of rats with chronic heart failure by long-term coenzyme Q10 treatment.
      A Sanbe, K Tanonaka, Y Niwano and S Takeo
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 51-56;

  4. Terleckyj, I

    1. The sigma receptor ligand (+/-)-BMY 14802 prevents methamphetamine-induced dopaminergic neurotoxicity via interactions at dopamine receptors.
      I Terleckyj and P K Sonsalla
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 44-50;

  5. Tesoriere, L

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  6. Tremont, S J

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  7. Trist, D G

    1. ADP beta S induces contraction of the human isolated urinary bladder through a purinoceptor subtype different from P2X and P2Y.
      S Palea, M Corsi, C Pietra, W Artibani, A Calpista, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 193-197;
    2. Quantification of the calcium antagonism of lacidipine by kinetic analysis.
      A Giacometti, D Micheli, G Gaviraghi and D G Trist
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 424-429;

  8. Truong, L

    1. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
      P A Cossum, L Truong, S R Owens, P M Markham, J P Shea and S T Crooke
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 89-94;

  9. Tsang, M

    1. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression.
      C C Chao, G Gekker, W S Sheng, S Hu, M Tsang and P K Peterson
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 198-203;

U

  1. Ukai, M

    1. Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the mu-selective opioid receptor agonist DAMGO in mice.
      J Itoh, M Ukai and T Kameyama
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 15-21;

  2. Ukmar, G

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  3. Unsworth, C D

    1. Characterization of a 5-hydroxytryptamine receptor in mouse neuroblastoma N18TG2 cells.
      C D Unsworth and P B Molinoff
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 246-255;

V

  1. Vaga, L

    1. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
      P Salvati, L Dho, G Ukmar, L Vaga, O Rimoldi and C Patrono
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 238-245;

  2. Valenza, M

    1. Effect of vitamin A administration on resistance of rat heart against doxorubicin-induced cardiotoxicity and lethality.
      L Tesoriere, M Ciaccio, M Valenza, A Bongiorno, E Maresi, R Albiero and M A Livrea
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 430-436;

  3. Veiga, S

    1. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
      M J Millan, J M Rivet, A Gobert, H Canton, S Veiga and K Bervoets
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 121-131;

W

  1. Wagner, G M

    1. Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.
      W E Perkins, R G Bianchi, S J Tremont, P W Collins, J J Casler, R L Fenton, G M Wagner, M P McGrath, J C Stolzenbach and D L Kowalski
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 151-156;

  2. Walker, E A

    1. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;

  3. Wang, L

    1. Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
      S K Salzman, G Kelly, J Chavin, L Wang, M A Puniak, C A Agresta and S Azim
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 322-328;

  4. Ward, J S

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  5. Weller, M

    1. The reduced unsubstituted pteroate moiety is required for folate toxicity of cultured cerebellar granule neurons.
      M Weller, A M Marini, B Martin and S M Paul
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 393-401;

  6. Wingfield, C P

    1. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
      J B Long, D D Rigamonti, M A Oleshansky, C P Wingfield and A Martinez-Arizala
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 358-366;

  7. Wong, D T

    1. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
      H E Shannon, F P Bymaster, D O Calligaro, B Greenwood, C H Mitch, B D Sawyer, J S Ward, D T Wong, P H Olesen and M J Sheardown
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 271-281;
    2. Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
      F P Bymaster, D T Wong, C H Mitch, J S Ward, D O Calligaro, D D Schoepp, H E Shannon, M J Sheardown, P H Olesen and P D Suzdak
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 282-289;

  8. Woods, J H

    1. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;

  9. Wurzer, J C

    1. New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells.
      J C Wurzer, R J Tallarida and M A Sirover
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 39-43;

Y

  1. Yoshida, S

    1. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
      J Imagawa, K Kamei, S Yoshida, I Sugo, T Koga and H Nabata
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 1-6;

Z

  1. Zaza, A

    1. Diverse electrophysiologic effects of propafenone and flecainide in canine Purkinje fibers: implications for antiarrhythmic drug classification.
      A Zaza, G Malfatto and P J Schwartz
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 336-343;

  2. Zernig, G

    1. In vivo determination of mu opioid receptor turnover in rhesus monkeys after irreversible blockade with clocinnamox.
      G Zernig, E R Butelman, J W Lewis, E A Walker and J H Woods
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 57-65;

  3. Zhang, J

    1. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
      J Zhang, L A Chiodo and A S Freeman
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 313-321;

  4. Zink, M H

    1. Adrenergic and nonadrenergic regulation of hindlimb blood flow during stress in rats.
      R H Alper and M H Zink
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 305-312;

  5. Zucchetti, M

    1. Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.
      T Colombo, M Zucchetti and M D'Incalci
      Journal of Pharmacology and Experimental Therapeutics April 1994, 269 (1) 22-27;
Back to top

In this issue

Advertisement